Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Smith Micro Software (SMSI)

$3.07 0.03 (0.99%)

14:21 EDT SMSI Stock Quote Delayed 15 Minutes

Volume:

Previous Close $3.04

Market Cap 75.68M

PE Ratio -7.49

EPS -0.41

Volume (Avg. Vol.) 15,036

Day's Range 2.99 - 3.09

52-Week Range 1.62 - 3.48

Dividend & Yield N/A (N/A)

SMSI Stock Predictions, Articles, and Smith Micro Software News

From InvestorPlace
From the Web

9 A-Rated Cheap Stocks to Consider

By Louis Navellier, Editor, Growth Investor Jul 20, 2018

The time has come to harness the upside these stocks offer -- and you won't break the bank to get into them.

50 Biggest Movers From Yesterday

From Benzinga Apr 9, 2019

Gainers Vital Therapies, Inc. (NASDAQ: VTL) shares climbed 41.73 percent to close at $0.7285 on Monday after the stock continued its spike from Friday following news of the...

48 Stocks Moving In Monday's Mid-Day Session

From Benzinga Apr 8, 2019

Gainers Vital Therapies, Inc. (NASDAQ: VTL) shares gained 34.8 percent to $0.6927 after the stock continued its spike from Friday following news of the company's stockholders...

Benzinga's Top Upgrades, Downgrades For April 8, 2019

From Benzinga Apr 8, 2019

Top Upgrades Analysts at Cowen & Co. upgraded Zillow Group Inc (NASDAQ: ZG) from Market Perform to Outperform. Zillow shares closed at $36.65 on Friday. Credit Suisse...

Chardan Capital Believes Smith Micro Software (NASDAQ: SMSI) Still Has Room to Grow

From Analyst Ratings Apr 7, 2019

Smith Micro Software (SMSI – Research Report) received a Buy rating and a $5 price target from Chardan Capital analyst James McIlree today. The company’s shares closed on Friday at $2.91, close to its 52-week high of $3.14. McIlree wrote: “We initiate coverage of Buy recommendation and a $5.00 price target. Over the coming quarters

32 Stocks Moving In Tuesday's Pre-Market Session

From Benzinga Apr 2, 2019

Gainers ADMA Biologics, Inc. (NASDAQ: ADMA) rose 70 percent to $6.92 in pre-market trading after the company announced FDA approval for its Asceniv Immune Globulin Intravenous,...

58 Biggest Movers From Yesterday

From Benzinga Apr 2, 2019

Gainers Pulmatrix Inc (NASDAQ: PULM) shares climbed 81.89 percent to close at $2.31 on Monday after the company reported that it entered into a binding term sheet with Cipla...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!